India  

Altria Sues Juul Over Patent Infringement

Video Credit: Wibbitz Top Stories - Duration: 01:31s - Published
Altria Sues Juul Over Patent Infringement

Altria Sues Juul Over Patent Infringement

Altria Sues Juul , Over Patent Infringement.

Altria Group, the maker of Marlboro cigarettes, said that its subsidiary, NJOY, filed a lawsuit with the U.S. International Trade Commission against Juul Labs on Aug.

22.

Altria Group, the maker of Marlboro cigarettes, said that its subsidiary, NJOY, filed a lawsuit with the U.S. International Trade Commission against Juul Labs on Aug.

22.

The complaint alleges that Juul infringed upon e-vapor patents owned by NJOY.

Altria is seeking a ban on Juul imports and sales.

Protecting our intellectual property is critical to achieving our vision, Murray Garnick, Altria General Counsel, via news release.

JUUL has infringed upon our patents through the sale of its imported products, and we ask the ITC to impose appropriate remedies in response to these trade violations, Murray Garnick, Altria General Counsel, via news release.

Altria acquired NJOY and its e-vapor products in June for $2.75 billion, CNBC reports.

One of the included products was NJOY ACE, which is the only pod-based e-vapor product that the FDA has given market authorizations.

.

We stand behind our intellectual property and will continue to pursue our infringement claims, Juul spokesperson, via statement.

Altria has also filed a lawsuit "against Juul in the U.S. District Court for the District of Delaware," CNBC reports.

.

Before acquiring NJOY, Altria heavily invested in Juul, but Altria's stake lost significant value following Juul's legal issues.

To date, Juul has settled multiple cases alleging that its marketing practices were deceptive and targeted youth.


You Might Like


💡 newsR Knowledge: Other News Mentions

CNBC CNBC American television business news channel

ConocoPhillips to Buy Marathon Oil [Video]

ConocoPhillips to Buy Marathon Oil

ConocoPhillips , to Buy Marathon Oil. ConocoPhillips , to Buy Marathon Oil. On May 29, ConocoPhillips agreed to acquire Marathon Oil in an all-stock deal valued at $17 billion, CNBC reports. The agreement will provide ConocoPhillips with an additional 2 billion barrels of U.S. inventory. This acquisition of Marathon Oil further deepens our portfolio and fits within our financial framework, adding high-quality, low cost of supply inventory adjacent to our leading U.S. unconventional position. , ConocoPhillips CEO Ryan Lance, via statement. ConocoPhillips' market cap will exceed $150 billion due to the deal. As an independent producer, ConocoPhillips will now be on the same scale as some big-time players, CNBC reports. For example, the company will become larger than BP but still be smaller than Shell, according to Andrew Dittmar, M&A analyst at Enverus. For example, the company will become larger than BP but still be smaller than Shell, according to Andrew Dittmar, M&A analyst at Enverus. While the deal is likely to face FTC scrutiny, the fact that Marathon's assets encompass multiple basins supports regulatory approval, Dittmar said. . Once the deal is complete, ConocoPhillips anticipates share buybacks worth $7 billion within the first year. After three years, that number is expected to grow to $20 billion. ConocoPhillips' larger rivals, Exxon Mobil and Chevron, announced blockbuster deals as well last year. ConocoPhillips' larger rivals, Exxon Mobil and Chevron, announced blockbuster deals as well last year

Credit: Wibbitz Top Stories    Duration: 01:31Published
Poll Highlights Gap Between Economic Data and Consumer Attitudes [Video]

Poll Highlights Gap Between Economic Data and Consumer Attitudes

Poll Highlights Gap , Between Economic Data and , Consumer Attitudes . CNBC reports that over half of Americans falsely believe the United States is in the middle of an economic recession. A recession is officially defined as an extended period of economic decline, usually after gross domestic product (GDP) declines for two or more consecutive quarters. . However, for the past several years, GDP has actually been increasing. Despite this, a recent Guardian/Harris poll found that 56% of respondents believe the U.S. is currently experiencing a recession. . Despite this, a recent Guardian/Harris poll found that 56% of respondents believe the U.S. is currently experiencing a recession. . At the same time, 58% of those polled believe that the Biden administration is responsible for the perceived economic downturn. In the first quarter of 2024, the GDP grew by 1.6%. . CNBC reports that the recent poll highlights the ongoing gap between economic feelings and economic data. . Consumer attitudes have been lagging amid persistent inflation and a consequently high cost of daily living. . The poll comes just six months ahead of the November presidential election which will pit President Joe Biden against former president Donald Trump. The poll comes just six months ahead of the November presidential election which will pit President Joe Biden against former president Donald Trump. The Biden administration has been trying to shift the mood of voters and recognize economic gains the U.S. has made in the wake of the COVID-19 pandemic. . The Biden administration has been trying to shift the mood of voters and recognize economic gains the U.S. has made in the wake of the COVID-19 pandemic.

Credit: Wibbitz Top Stories    Duration: 01:31Published
Microsoft Announces New Surface PCs With AI Chips [Video]

Microsoft Announces New Surface PCs With AI Chips

Microsoft Announces , New Surface PCs With AI Chips. On May 20, Microsoft announced that it will be releasing a Surface Laptop and Surface Pro tablet with Qualcomm AI chips, CNBC reports. . On May 20, Microsoft announced that it will be releasing a Surface Laptop and Surface Pro tablet with Qualcomm AI chips, CNBC reports. . Qualcomm's Arm-based chips deliver longer battery life. Other computer makers such as Dell, HP, Acer and more are also debuting AI-ready PCs that will offer Microsoft's Copilot AI chatbot. PCs equipped with AMD and Intel chips that adopt the Copilot+ standard will be released at a later date, Microsoft said. . PCs equipped with AMD and Intel chips that adopt the Copilot+ standard will be released at a later date, Microsoft said. . Copilot+ computers will begin at $999. Pre-orders are currently being accepted. . The devices will be available in June. The new offering comes almost four months after Microsoft CEO Satya Nadella said on an earnings call that "in 2024, AI will become a first-class part of every PC." . The new offering comes almost four months after Microsoft CEO Satya Nadella said on an earnings call that "in 2024, AI will become a first-class part of every PC." . On May 20, Microsoft shares closed at $425.34, up 1.2%. Qualcomm increased 2% to $197.76, a record close

Credit: Wibbitz Top Stories    Duration: 01:30Published
Hims and Hers to Offer Weight Loss Injections [Video]

Hims and Hers to Offer Weight Loss Injections

Hims and Hers , to Offer Weight Loss Injections. GLP-1 medications like Ozempic and Wegovy have become increasingly popular. However, the market has faced some supply constraints recently because of that popularity. On May 20, Hims & Hers Health announced that it will be providing access to compounded GLP-1 weight loss injections, CNBC reports. . Company shares jumped over 30% following the announcement. Compounded versions of medications are created by certain manufacturers who meet FDA requirements when there are medication shortages. However, the products are not tested for safety and efficacy by the FDA. The new offering of compounded GLP-1 medications can be accessed by getting a prescription from a health care provider on the Hims & Hers site. Branded GLP-1 injections will be made available once the supply becomes more consistent. The price for compounded injections will start at $199 per month, CNBC reports. . Prior to announcing its GLP-1 offerings, Hims & Hers revealed in an earnings report... ... that it anticipates its weight loss program to garner over $100 million worth of revenue by December 2025. Hims & Hers CEO Andrew Dudum said that he is "confident" that a steady supply of the compounded injections will be available for customers. We have a certain degree of exclusivity with that facility that will guarantee our consumers consistent volume and supply, Hims & Hers CEO Andrew Dudum, via statement

Credit: Wibbitz Top Stories    Duration: 01:31Published
Key Federal Reserve Inflation Gauge Rose 2.8% in March [Video]

Key Federal Reserve Inflation Gauge Rose 2.8% in March

Key Federal Reserve Inflation Gauge , Rose 2.8% in March. According to Commerce Department data released on April 26. the personal consumption expenditures (PCE) price index, not including food or energy, rose 2.8% year-over-year in March. . That exceeded Dow Jones estimates of 2.7%, CNBC reports. . When also accounting for food and energy, the all-items PCE measure rose 2.7%, which was above the 2.6% estimate. Inflation reports released this morning were not as a hot as feared, , George Mateyo, chief investment officer at Key Wealth, via CNBC. ... but investors should not get overly anchored to the idea that inflation has been completely cured and the Fed will be cutting interest rates in the near-term, George Mateyo, chief investment officer at Key Wealth, via CNBC. The prospects of rate cuts remain, but they are not assured, and the Fed will likely need weakness in the labor market before they have the confidence to cut, George Mateyo, chief investment officer at Key Wealth, via CNBC. Consumers continue to spend despite higher prices, CNBC reports. Personal spending increased 0.8% in March, while personal income rose 0.5%. The personal saving rate dropped to 3.2% as more people are having to dip into their savings to cover the cost of living. The Fed continues to target 2% inflation, which the core PCE has exceeded for the last three years, CNBC reports.

Credit: Wibbitz Top Stories    Duration: 01:30Published

Food and Drug Administration Food and Drug Administration United States federal agency

Experts Question Claim That Yogurt Can Help Prevent Type 2 Diabetes [Video]

Experts Question Claim That Yogurt Can Help Prevent Type 2 Diabetes

Experts Question Claim , That Yogurt Can Help , Prevent Type 2 Diabetes. Associated Press reports that the United States Food and Drug Association's recently allowed yogurt producers to claim it reduces the risk of Type 2 diabetes. . However, at the time, the agency acknowledged that the claim is based on limited evidence. In 2018, Danone North America, the U.S. side of the French firm, sought FDA clearance for making the "qualified health claim.". Qualified health claims lack full scientific support but are allowed as long as manufacturers include a disclaimer to avoid misleading the public. Similar qualified health claims have been allowed for dietary supplements since 2000 and for food products since 2002. . In March of 2024, the FDA granted Danone's request. . According to the FDA, there is some evidence that eating at least 2 cups of yogurt a week could reduce the risk of developing Type 2 diabetes, which impacts about 36 million Americans. Critics of the FDA's decision have countered that the claim is not based on randomized control trials which could prove or disprove yogurt's purported health benefits. Critics of the FDA's decision have countered that the claim is not based on randomized control trials which could prove or disprove yogurt's purported health benefits. The Center for Science in the Public Interest, an advocacy group, cautions that no single food can reduce the risk of developing a disease linked to overall diet. AP reports that experts have expressed concerns that the label change could encourage people to eat yogurt high in sugar, which could increase the risk of developing diabetes

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Testing Reveals Bird Flu Virus in 1 in 5 Milk Samples [Video]

FDA Testing Reveals Bird Flu Virus in 1 in 5 Milk Samples

FDA Testing Reveals , Bird Flu Virus , in 1 in 5 Milk Samples. 'Time' reports that the Food and Drug Administration (FDA) has warned that traces of bird flu have been found in nearly one-fifth of commercial milk samples tested. . In a statement released on the agency's website, the FDA said that traces of the virus do not necessarily indicate a risk to consumers. . According to the FDA, more tests are needed to confirm if intact pathogens that remain infectious are present in the samples. Those tests would determine , "whether there is any risk of illness associated with consuming the product.". 'Time' reports that the results of the study come as a stark warning of how quickly the virus is spreading among dairy cows in the U.S. The virus has already killed millions of birds globally, raising both health and food security concerns, as well as spooking global markets. The virus has already killed millions of birds globally, raising both health and food security concerns, as well as spooking global markets. So far, the Department of Agriculture has already confirmed 33 infected herds across eight states, including Texas, Michigan and Ohio. So far, the Department of Agriculture has already confirmed 33 infected herds across eight states, including Texas, Michigan and Ohio. In an effort to understand the extent of the outbreak and potentially contain it, the USDA has implemented mandatory testing of cows moving across state borders. Authorities have stressed that the current risk to humans remains low, with only one identified human case in the U.S. this year. . To date, the retail milk studies have shown no results that would change our assessment that the commercial milk supply is safe. , FDA statement, via 'Time'

Credit: Wibbitz Top Stories    Duration: 01:31Published
Is Cereal Good for You? [Video]

Is Cereal Good for You?

Is Cereal Good for You?. 'USA Today' reports that these are the 10 most-purchased cereals in America, according to data compiled by Google:. Honey Nut Cheerios, Frosted Flakes, Cap'n Crunch, Kellogg's Froot Loops, Cinnamon Toast Crunch, . Honey Nut Cheerios, Frosted Flakes, Cap'n Crunch, Kellogg's Froot Loops, Cinnamon Toast Crunch, . Honey Nut Cheerios, Frosted Flakes, Cap'n Crunch, Kellogg's Froot Loops, Cinnamon Toast Crunch, . Honey Nut Cheerios, Frosted Flakes, Cap'n Crunch, Kellogg's Froot Loops, Cinnamon Toast Crunch, . Honey Nut Cheerios, Frosted Flakes, Cap'n Crunch, Kellogg's Froot Loops, Cinnamon Toast Crunch, . Lucky Charms, Special K, Chex, Cheerios and Rice Krispies. Lucky Charms, Special K, Chex, Cheerios and Rice Krispies. Lucky Charms, Special K, Chex, Cheerios and Rice Krispies. Lucky Charms, Special K, Chex, Cheerios and Rice Krispies. Lucky Charms, Special K, Chex, Cheerios and Rice Krispies. Cereal requires minimal preparation, is shelf-stable, convenient, affordable and can be a good way to get some fiber in the morning, Leslie Bonci, a sports dietitian for the Kansas City Chiefs and founder of Active Eating Advice, via 'USA Today'. Cereal can also be a great way to get micronutrients and one of the best ways to ensure B vitamin intake is included in your diet. , Leslie Bonci, a sports dietitian for the Kansas City Chiefs and founder of Active Eating Advice, via 'USA Today'. However, "cereals that are made of refined grains – grains that have had parts of the grain kernel removed – are lower in fiber and nutrients," according to registered dietitian Kate Zeratsky. Added sugars are also a concern. For adults, the FDA advises consuming no more than 50 grams of added sugars per day as part of a 2,000-calorie diet. The agency recommends that children don't exceed 25 grams. But some cereals contain large amounts of added sugars, such as Post's Golden Crisp, which has 21 grams of added sugars in just one cup. Zeratsky suggests sticking with cereal brands that have added sugars "in the single digits" that also contain whole grains. Cheerios and Rice Krispies contain low amounts of added sugars, . Cheerios and Rice Krispies contain low amounts of added sugars, . while Grape Nuts, Cracklin' Oat Bran, Wheaties, Shredded Wheat, Raisin Bran and Special K are high in dietary fiber and whole grains. while Grape Nuts, Cracklin' Oat Bran, Wheaties, Shredded Wheat, Raisin Bran and Special K are high in dietary fiber and whole grains. while Grape Nuts, Cracklin' Oat Bran, Wheaties, Shredded Wheat, Raisin Bran and Special K are high in dietary fiber and whole grains. while Grape Nuts, Cracklin' Oat Bran, Wheaties, Shredded Wheat, Raisin Bran and Special K are high in dietary fiber and whole grains. while Grape Nuts, Cracklin' Oat Bran, Wheaties, Shredded Wheat, Raisin Bran and Special K are high in dietary fiber and whole grains

Credit: Wibbitz Top Stories    Duration: 01:31Published
Latest Weight-Loss Drug Faces Shortages [Video]

Latest Weight-Loss Drug Faces Shortages

Latest Weight-Loss Drug , Faces Shortages . The United States Food and Drug Administration (FDA) says that high demand has left the latest weight-loss drug, Zepbound, in short supply. 'Newsweek' reports that the Eli Lilly product is expected to experience limited availability through Q2 of 2024 as surging demand has outpaced the manufacturer's expectations. We have experienced an unparalleled surge in demand for our type 2 diabetes and obesity medicines, Eli Lilly spokesperson, via 'Newsweek'. We recognize this situation may cause a disruption in peoples' treatment regimens and are working with purpose and urgency to help meet the surge in demand, Eli Lilly spokesperson, via 'Newsweek'. The FDA said that Novo Nordisk's weight-loss drug, Wegovy, is also experiencing a widespread supply shortage with no end in sight for the drug's limited availability. By the year 2030, 'Newsweek' reports that the weight-loss drug market is expected to grow to about $100 billion. We expect our investments in manufacturing and supply capacity to progressively increase production of our medicines throughout 2024 and beyond, Eli Lilly spokesperson, via 'Newsweek'. Over the past year, manufacturer Eli Lilly has already seen share prices rise over 102%. The company has announced plans to expand operations to meet increased demand for its incretin products which are used in the firm's diabetes treatments. . Incretin mimics gut hormones that regulate blood sugar while also suppressing appetite

Credit: Wibbitz Top Stories    Duration: 01:30Published